Live Status Check

NCT04262466 Recruiting Status

Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the data only lists drug combinations and treatments, but does not specify what medical condition or disease these treatments are targeting. the brief summary appears to be incomplete (showing only "localhost:3000/trial/"), and there are no keywords provided that would indicate the underlying health condition being studied. clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 8:49 AM UTC

NCT04262466 Status Summary

NCT NumberNCT04262466
Recruiting StatusRecruiting
ConditionI cannot determine the primary medical condition from the provided information. The data only lists drug combinations and treatments, but does not specify what medical condition or disease these treatments are targeting. The brief summary appears to be incomplete (showing only "localhost:3000/trial/"), and there are no keywords provided that would indicate the underlying health condition being studied.
PhaseClinical Trial
Target Enrollment727 participants
Active Locations22 sites in the US
SponsorImmunocore Ltd
Last Updated on CT.govJuly 25, 2025 (Jul 25, 2025)

About NCT04262466 Enrollment Status

As of March 2, 2026: Clinical trial NCT04262466 is currently recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the data only lists drug combinations and treatments, but does not specify what medical condition or disease these treatments are targeting. the brief summary appears to be incomplete (showing only "localhost:3000/trial/"), and there are no keywords provided that would indicate the underlying health condition being studied. is actively seeking new participants at 22 locations across the United States. The study is sponsored by Immunocore Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT04262466

Is NCT04262466 still recruiting?

Yes, NCT04262466 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT04262466 recruiting?

This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT04262466?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT04262466 status last updated?

The official ClinicalTrials.gov record for NCT04262466 was last updated Jul 25, 2025 (July 25, 2025). HelloStudys verifies this status automatically.

Browse More I cannot determine the primary medical condition from the provided information. The data only lists drug combinations and treatments, but does not specify what medical condition or disease these treatments are targeting. The brief summary appears to be incomplete (showing only "localhost:3000/trial/"), and there are no keywords provided that would indicate the underlying health condition being studied. Trials

Ready to Apply?

Check your eligibility for this clinical trial